代表作(五年内)  | 
     1.   Liu D*, Ke J*, Liu Y, Rao  H, Tang Z, Liu Y, Zhang Z, You L, Luo X, Sun Z, He Z, Li F, Qiu Z, Hu J,  Mbadhi MN, Tang J#, Wu F#, Li S#. The interaction between PDCD4 and YB1 is  critical for cervical cancer stemness and cisplatin resistance[J]. Mol  Carcinog. 2021 Sep 9.  2.   Li S*, Gao G*, Wu F, Liu  D, Zhao H, Ke J, Liu Y, Li F, Li J, Chen Z, Tang Z, Bai L, Zhang J, Zheng W#,  Chen X#. Programmed cell death protein 4 deficiency suppresses foam cell  formation by activating autophagy in advanced glycation end-product low-density  lipoprotein-induced macrophages[J]. J Cell Biochem. 2018 Nov 13.  3.   Zhang C, Sheng L, Yuan M,  Hu J, Meng Y, Wu Y, Chen L, Yu H, Li S#, Zheng G#, Qiu Z#. Orlistat delays  hepatocarcinogenesis in mice with hepatic co-activation of AKT and c-Met[J].  Toxicol Appl Pharmacol. 2020 Apr 1;392:114918.  4.   Ke J*, Gu C*, Zhang H, Liu  Y, Zhang W, Rao H, Li S#, Wu F#. Nucleolin Promotes Cisplatin Resistance in  Cervical Cancer by the YB1-MDR1 Pathway[J]. J Oncol. 2021 Apr  21;2021:9992218.   |